These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 34172168)
21. PRECORDIAL PAIN, LEUKOCYTOSIS AND BICYTOPENIA IN A TEENAGER WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS UNDER IMMUNOSUPPRESSIVE THERAPY. Vieira MS; Andrade FR; Brandão LMKR; Nóbrega VTD; Guissa VR; Provenza JR Rev Paul Pediatr; 2019; 37(2):252-256. PubMed ID: 30810692 [TBL] [Abstract][Full Text] [Related]
22. An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis. Davì S; Consolaro A; Guseinova D; Pistorio A; Ruperto N; Martini A; Cron RQ; Ravelli A; J Rheumatol; 2011 Apr; 38(4):764-8. PubMed ID: 21285158 [TBL] [Abstract][Full Text] [Related]
23. Primary varicella infection in children with systemic juvenile idiopathic arthritis under tocilizumab therapy. Nozawa T; Nishimura K; Ohara A; Hara R; Ito S Mod Rheumatol; 2019 May; 29(3):558-562. PubMed ID: 27846755 [TBL] [Abstract][Full Text] [Related]
24. Systemic onset juvenile idiopathic arthritis with macrophage activation syndrome misdiagnosed as Kawasaki disease: case report and literature review. Kumar S; Vaidyanathan B; Gayathri S; Rajam L Rheumatol Int; 2013 Apr; 33(4):1065-9. PubMed ID: 21132551 [TBL] [Abstract][Full Text] [Related]
25. Performances of the "MS-score" And "HScore" in the diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis patients. Sag E; Keskin A; Atalay E; Demir S; Cuceoglu MK; Akca UK; Batu ED; Bilginer Y; Ozen S Rheumatol Int; 2021 Jan; 41(1):87-93. PubMed ID: 33215249 [TBL] [Abstract][Full Text] [Related]
26. Remission of Refractory Systemic-Onset Juvenile Idiopathic Arthritis After Treatment With Siltuximab. Leurs A; Launay D; Terriou L; Hatron PY; Quartier P; Hachulla E J Clin Rheumatol; 2019 Jun; 25(4):40-42. PubMed ID: 29485546 [No Abstract] [Full Text] [Related]
27. An important complication of a child with juvenile idiopathic arthritis: macrophage activation syndrome. Reddy YN; Bhatia N; Scott JX; Nagarajan P BMJ Case Rep; 2013 Sep; 2013():. PubMed ID: 24027253 [TBL] [Abstract][Full Text] [Related]
28. Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Takakura M; Shimizu M; Irabu H; Sakumura N; Inoue N; Mizuta M; Nakagishi Y; Yachie A Clin Immunol; 2019 Nov; 208():108252. PubMed ID: 31449879 [TBL] [Abstract][Full Text] [Related]
29. Occult macrophage activation syndrome in systemic-onset juvenile idiopathic arthritic syndrome--a case report. Zeng P; Li F; Zeng H Acta Reumatol Port; 2013; 38(3):196-200. PubMed ID: 24149017 [TBL] [Abstract][Full Text] [Related]
30. Systemic juvenile idiopathic arthritis: a review. Hay AD; Ilowite NT Pediatr Ann; 2012 Nov; 41(11):. PubMed ID: 23814932 [No Abstract] [Full Text] [Related]
31. 50 Years Ago in TheJournalofPediatrics: The Liver in Juvenile Idiopathic Arthritis and the Evolution of Liver Function Tests. Kaj-Carbaidwala B J Pediatr; 2020 Aug; 223():56. PubMed ID: 32711752 [No Abstract] [Full Text] [Related]
32. Thrombocytopaenia in Systemic Juvenile Idiopathic Arthritis: Not Always Macrophage Activation Syndrome! Gupta R; Bhattarai D; Vignesh P; Suri D J Paediatr Child Health; 2018 Sep; 54(9):1052. PubMed ID: 30178590 [No Abstract] [Full Text] [Related]
34. Validation of Classification Criteria of Macrophage Activation Syndrome in Japanese Patients With Systemic Juvenile Idiopathic Arthritis. Shimizu M; Mizuta M; Yasumi T; Iwata N; Okura Y; Kinjo N; Umebayashi H; Kubota T; Nakagishi Y; Nishimura K; Yashiro M; Yasumura J; Yamazaki K; Wakiguchi H; Okamoto N; Mori M Arthritis Care Res (Hoboken); 2018 Sep; 70(9):1412-1415. PubMed ID: 29195002 [TBL] [Abstract][Full Text] [Related]
35. [Macrophage activation syndrome in a patient with systemic type juvenile idiopathic arthritis]. Qiu JJ; Wei M Zhonghua Er Ke Za Zhi; 2005 Nov; 43(11):874-5. PubMed ID: 16316546 [No Abstract] [Full Text] [Related]
36. Tapering Doses of Methylprednisolone Pulse in the Treatment of Macrophage Activation Syndrome Associated with Systemic Juvenile Idiopathic Arthritis. Loganathan S; Banday A; Jindal AK; Sudhakar M; Patra N; Pulipaka S; Bansal R; Mohanandia B; Singh S Indian J Pediatr; 2021 Oct; 88(10):1056. PubMed ID: 34196929 [No Abstract] [Full Text] [Related]
37. Canakinumab for Pulmonary Artery Hypertension and Macrophage Activation Syndrome Associated with Uncontrolled Systemic Juvenile Idiopathic Arthritis. Paim LB; Landim MLL; Firmino SL; Monteiro CMBE; Cordeiro LR; de Araujo FG; de Carvalho JF Indian J Pediatr; 2021 Jun; 88(6):608-609. PubMed ID: 33742412 [No Abstract] [Full Text] [Related]
38. An unusual presentation of purine nucleoside phosphorylase deficiency mimicking systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome. Arduini A; Marasco E; Marucci G; Pardeo M; Insalaco A; Caiello I; Moneta GM; Prencipe G; De Benedetti F; Bracaglia C Pediatr Rheumatol Online J; 2019 May; 17(1):25. PubMed ID: 31118063 [TBL] [Abstract][Full Text] [Related]
39. FDG-PET in macrophage activation syndrome associated with systemic juvenile idiopathic arthritis. Shimizu M; Ikawa Y; Mizuta M; Takakura M; Inoue N; Nishimura R; Yachie A Pediatr Int; 2017 Apr; 59(4):509-511. PubMed ID: 28401744 [TBL] [Abstract][Full Text] [Related]